semaglutide for heart FDA Clears Cardiac Risk Reduction in Diabetic Patients Semaglutide dose may matter more
Description
Semaglutide, on the other hand, mimics GLP-1, a hormone that is involved in the regulation of blood sugar and the digestive system
This instructional content is for educational purposes only and is not a replacement for medical advice
It starts at 0.25mg and gradually increases, if clinically indicated, over 17 weeks
Victoza (Injection) Indication : Type 2 Diabetes, cardiovascular risk reduction Frequency : Daily Saxenda (Injection) Indication : Chronic weight management Frequency : Daily 4
Liraglutide lowers cardiometabolic risk by reducing metabolic syndrome severity, abdominal obesity, and inflammation [42, 43]
Therefore, most specific drug information is unavailable
